Alexandria Forbes - MeiraGTx Holdings President CEO, Director
| MGTX Stock | USD 6.33 0.40 6.75% |
CEO
Dr. Alexandria Forbes, Ph.D. is President, Chief Executive Officer, Director of the Company since March 2015. Prior to joining MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015, and served as a member of its board of directors until June 2018. Prior to Kadmon Holdings, Inc., Dr. Forbes spent eleven years as a healthcare investor at Sivik Global Healthcare, a healthcare hedge fund, from August 2001 to November 2008, and at Meadowvale Asset Management, a healthcare hedge fund, from January 2010 to June 2012. Before entering the hedge fund industry, Dr. Forbes was a Human FrontiersHoward Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center from March 1997 to September 2000. Prior to this, Dr. Forbes was a research fellow at Duke University, and also at the Carnegie Institute at Johns Hopkins University since 2015.
| Age | 59 |
| Tenure | 9 years |
| Professional Marks | Ph.D |
| Address | 450 East 29th Street, New York, NY, United States, 10016 |
| Phone | 646 860 7985 |
| Web | https://meiragtx.com |
Alexandria Forbes Latest Insider Activity
Tracking and analyzing the buying and selling activities of Alexandria Forbes against MeiraGTx Holdings stock is an integral part of due diligence when investing in MeiraGTx Holdings. Alexandria Forbes insider activity provides valuable insight into whether MeiraGTx Holdings is net buyers or sellers over its current business cycle. Note, MeiraGTx Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell MeiraGTx Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Alexandria Forbes over two months ago Disposition of 25777 shares by Alexandria Forbes of MeiraGTx Holdings at 6.63 subject to Rule 16b-3 | ||
Alexandria Forbes over six months ago Acquisition by Alexandria Forbes of 48750 shares of MeiraGTx Holdings subject to Rule 16b-3 | ||
Alexandria Forbes over six months ago Disposition of 1000 shares by Alexandria Forbes of MeiraGTx Holdings subject to Rule 16b-3 | ||
Alexandria Forbes over six months ago Disposition of 2000 shares by Alexandria Forbes of MeiraGTx Holdings subject to Rule 16b-3 |
MeiraGTx Holdings Management Efficiency
The company has return on total asset (ROA) of (0.3666) % which means that it has lost $0.3666 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9151) %, meaning that it created substantial loss on money invested by shareholders. MeiraGTx Holdings' management efficiency ratios could be used to measure how well MeiraGTx Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.27 in 2024. Return On Capital Employed is likely to drop to -0.55 in 2024. At this time, MeiraGTx Holdings' Non Currrent Assets Other are fairly stable compared to the past year. Intangible Assets is likely to rise to about 1.5 M in 2024, whereas Total Assets are likely to drop slightly above 247.2 M in 2024.Similar Executives
| Found 11 records | CEO Age | ||
| Matthew CPA | Uniqure NV | 52 | |
| Alexander Cumbo | Solid Biosciences LLC | 53 | |
| Andrew MBA | C4 Therapeutics | 53 | |
| Junyuan Wang | Nuvation Bio | 51 | |
| Barry PharmD | Connect Biopharma Holdings | 67 | |
| Norbert Bischofberger | Kronos Bio | 68 | |
| Sean Brynjelsen | Eton Pharmaceuticals | 52 | |
| David Hung | Nuvation Bio | 63 | |
| Ilan Ganot | Solid Biosciences LLC | 50 | |
| Daniel MBA | Acumen Pharmaceuticals | 54 | |
| Kevin Koch | Edgewise Therapeutics | 64 | |
Management Performance
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.37 |
MeiraGTx Holdings PLC Leadership Team
Elected by the shareholders, the MeiraGTx Holdings' board of directors comprises two types of representatives: MeiraGTx Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MeiraGTx. The board's role is to monitor MeiraGTx Holdings' management team and ensure that shareholders' interests are well served. MeiraGTx Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MeiraGTx Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alexandria Forbes, President CEO, Director | ||
| Robert MD, Chief Officer | ||
| Tim Randall, Senior Controls | ||
| Christine Sheehy, Senior Integration | ||
| Richard BA, COO CFO | ||
| Joel Brooks, VP Fin | ||
| Alastair Leighton, Senior Chain | ||
| Stuart Naylor, Chief Development Officer | ||
| Robert JD, General Secretary | ||
| Michel MD, Head Ophthalmology |
MeiraGTx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MeiraGTx Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (162.80) % | ||||
| Current Valuation | 427.31 M | ||||
| Shares Outstanding | 78.15 M | ||||
| Shares Owned By Insiders | 24.24 % | ||||
| Shares Owned By Institutions | 55.12 % | ||||
| Number Of Shares Shorted | 1.66 M | ||||
| Price To Earning | (1.93) X | ||||
| Price To Book | 4.84 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MeiraGTx Stock Analysis
When running MeiraGTx Holdings' price analysis, check to measure MeiraGTx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeiraGTx Holdings is operating at the current time. Most of MeiraGTx Holdings' value examination focuses on studying past and present price action to predict the probability of MeiraGTx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeiraGTx Holdings' price. Additionally, you may evaluate how the addition of MeiraGTx Holdings to your portfolios can decrease your overall portfolio volatility.